Source: Circulation. Unidade: FMRP
Subjects: VELHICE, INFARTO DO MIOCÁRDIO
ABNT
WHITE, Harvey D. et al. Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction. Circulation, v. 29, p. 3391-3399, 2005Tradução . . Acesso em: 17 nov. 2024.APA
White, H. D., Aylward, P. E. G., Huang, Z., Dalby, A., Weaver, D., Barvik, S., et al. (2005). Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction. Circulation, 29, 3391-3399.NLM
White HD, Aylward PEG, Huang Z, Dalby A, Weaver D, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, Gilst WH van, Zannad F, McMurray JJV, Califf RM, Pfeffer MA. Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction. Circulation. 2005 ; 29 3391-3399.[citado 2024 nov. 17 ]Vancouver
White HD, Aylward PEG, Huang Z, Dalby A, Weaver D, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, Gilst WH van, Zannad F, McMurray JJV, Califf RM, Pfeffer MA. Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction. Circulation. 2005 ; 29 3391-3399.[citado 2024 nov. 17 ]